LEAP Study Sponsors
 |
Immune Tolerance Network
www.immunetolerance.org
The Immune Tolerance Network (ITN) is an international collaboration of researchers that conducts clinical research of new immune tolerance therapies – highly targeted treatments that prevent harmful immune responses, while leaving the protective immune response unhindered. Targeting autoimmune diseases, islet, kidney and liver transplantation and allergy and asthma, the ITN is supported by the National Institute for Allergy and Infectious Diseases, the National Institute for Diabetes and Digestive and Kidney Diseases and the Juvenile Diabetes Research Foundation.
|
 |
National Institute of Allergy and Infectious Diseases
www.niaid.nih.gov
The National Institute of Allergy and Infectious Diseases (NIAID) conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 50 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world. |
 |
The Food Allergy Initiative
www.foodallergyinitiative.org
The Food Allergy Initiative (FAI) is a national non-profit organization dedicated to finding a cure for life-threatening food allergies. In addition to funding research and clinical activities to identify and treat those at risk, FAI supports public policy initiatives to create a safer environment for those afflicted and educational programmes to heighten awareness among health and child care workers, schools, camps, and members of the hospitality and food service industries about food allergies and the danger of anaphylaxis. Since 1998, by raising and investing over $25 million in basic and clinical research around the world, FAI has made substantial progress towards their goal of finding a cure by 2010 as well as making the world safer for those afflicted.
|
The Leap Study also acknowledges the gracious support of:
[top]
|
